Literature DB >> 23284046

Altered sulfide (H(2)S) metabolism in ethylmalonic encephalopathy.

Valeria Tiranti1, Massimo Zeviani.   

Abstract

Hydrogen sulfide (sulfide, H(2)S) is a colorless, water-soluble gas with a typical smell of rotten eggs. In the past, it has been investigated for its role as a potent toxic gas emanating from sewers and swamps or as a by-product of industrial processes. At high concentrations, H(2)S is a powerful inhibitor of cytochrome c oxidase; in trace amounts, it is an important signaling molecule, like nitric oxide (NO) and carbon monoxide (CO), together termed "gasotransmitters." This review will cover the physiological role and the pathogenic effects of H(2)S, focusing on ethylmalonic encephalopathy, a human mitochondrial disorder caused by genetic abnormalities of sulfide metabolism. We will also discuss the options that are now conceivable for preventing genetically driven chronic H(2)S toxicity, taking into account that a complete understanding of the physiopathology of H(2)S has still to be achieved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23284046      PMCID: PMC3579397          DOI: 10.1101/cshperspect.a011437

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  71 in total

1.  Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?

Authors:  Rui Wang
Journal:  FASEB J       Date:  2002-11       Impact factor: 5.191

2.  Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?

Authors:  M Y Ali; C Y Ping; Y-Yp Mok; L Ling; M Whiteman; M Bhatia; P K Moore
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

Review 3.  The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver.

Authors:  Stefano Fiorucci; Eleonora Distrutti; Giuseppe Cirino; John L Wallace
Journal:  Gastroenterology       Date:  2006-03-06       Impact factor: 22.682

4.  Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy.

Authors:  Carlo Viscomi; Alberto B Burlina; Imad Dweikat; Mario Savoiardo; Costanza Lamperti; Tatjana Hildebrandt; Valeria Tiranti; Massimo Zeviani
Journal:  Nat Med       Date:  2010-07-25       Impact factor: 53.440

5.  Cyanide intoxication--III. On the analogous and different effects provoked by non-lethal and lethal challenged doses.

Authors:  A M Buzaleh; E S Vazquez; A M del Carmen Batlle
Journal:  Gen Pharmacol       Date:  1990

6.  Electrophysiological effects of hydrogen sulfide on pacemaker cells in sinoatrial nodes of rabbits.

Authors:  Meng Xu; Yu-Ming Wu; Qian Li; Xin Wang; Rui-Rong He
Journal:  Sheng Li Xue Bao       Date:  2008-04-25

7.  Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy.

Authors:  Valeria Tiranti; Carlo Viscomi; Tatjana Hildebrandt; Ivano Di Meo; Rossana Mineri; Cecilia Tiveron; Michael D Levitt; Alessandro Prelle; Gigliola Fagiolari; Marco Rimoldi; Massimo Zeviani
Journal:  Nat Med       Date:  2009-01-11       Impact factor: 53.440

8.  Hydrogen sulfide protects neurons from oxidative stress.

Authors:  Yuka Kimura; Hideo Kimura
Journal:  FASEB J       Date:  2004-05-20       Impact factor: 5.191

Review 9.  Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.

Authors:  Peter Ferdinandy; Rainer Schulz; Gary F Baxter
Journal:  Pharmacol Rev       Date:  2007-11-29       Impact factor: 25.468

10.  An antibiotic-responsive mouse model of fulminant ulcerative colitis.

Authors:  Silvia S Kang; Seth M Bloom; Lyse A Norian; Michael J Geske; Richard A Flavell; Thaddeus S Stappenbeck; Paul M Allen
Journal:  PLoS Med       Date:  2008-03-04       Impact factor: 11.069

View more
  18 in total

Review 1.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Authors:  Katalin Módis; Eelke M Bos; Enrico Calzia; Harry van Goor; Ciro Coletta; Andreas Papapetropoulos; Mark R Hellmich; Peter Radermacher; Frédéric Bouillaud; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 2.  Cysteine Metabolism in Neuronal Redox Homeostasis.

Authors:  Bindu D Paul; Juan I Sbodio; Solomon H Snyder
Journal:  Trends Pharmacol Sci       Date:  2018-03-09       Impact factor: 14.819

3.  Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine.

Authors:  Mustafa Kılıç; Özge Dedeoğlu; Rahşan Göçmen; Selman Kesici; Deniz Yüksel
Journal:  Metab Brain Dis       Date:  2016-11-09       Impact factor: 3.584

Review 4.  Mitochondrial Dysfunction and Redox Homeostasis Impairment as Pathomechanisms of Brain Damage in Ethylmalonic Encephalopathy: Insights from Animal and Human Studies.

Authors:  Mateus Grings; Moacir Wajner; Guilhian Leipnitz
Journal:  Cell Mol Neurobiol       Date:  2020-10-09       Impact factor: 5.046

Review 5.  Gastrointestinal and hepatic manifestations of mitochondrial disorders.

Authors:  Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2013-05-15       Impact factor: 4.982

6.  The cytochrome bd oxidase of Escherichia coli prevents respiratory inhibition by endogenous and exogenous hydrogen sulfide.

Authors:  Sergey Korshunov; Karin R C Imlay; James A Imlay
Journal:  Mol Microbiol       Date:  2016-05-02       Impact factor: 3.501

7.  Effects of a block in cysteine catabolism on energy balance and fat metabolism in mice.

Authors:  Julie Niewiadomski; James Q Zhou; Heather B Roman; Xiaojing Liu; Lawrence L Hirschberger; Jason W Locasale; Martha H Stipanuk
Journal:  Ann N Y Acad Sci       Date:  2016-01       Impact factor: 5.691

Review 8.  Homeostatic impact of sulfite and hydrogen sulfide on cysteine catabolism.

Authors:  Joshua B Kohl; Anna-Theresa Mellis; Guenter Schwarz
Journal:  Br J Pharmacol       Date:  2018-09-27       Impact factor: 8.739

9.  Acute and Chronic Management in an Atypical Case of Ethylmalonic Encephalopathy.

Authors:  Thomas M Kitzler; Indra R Gupta; Bradley Osterman; Chantal Poulin; Yannis Trakadis; Paula J Waters; Daniela C Buhas
Journal:  JIMD Rep       Date:  2018-10-23

10.  Severe early onset ethylmalonic encephalopathy with West syndrome.

Authors:  Laura Papetti; Giacomo Garone; Livia Schettini; Carla Giordano; Francesco Nicita; Paola Papoff; Massimo Zeviani; Vincenzo Leuzzi; Alberto Spalice
Journal:  Metab Brain Dis       Date:  2015-07-21       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.